Diagnostics

Adjuvant Capital is a life sciences investment fund that backs ambitious companies developing drugs, vaccines, diagnostics, medical devices, and other technologies to address critical global public health challenges. It focuses on historically overlooked market segments, leveraging expertise to translate opportunities into social and financial returns. The firm's investment model is heavily influenced by global trends such as climate change and antimicrobial resistance.

Aisling Capital is a leading investment firm focused on healthcare. They invest across various stages and structures in companies developing and commercializing innovative healthcare products and services. Their team's expertise allows them to provide strategic guidance and capital to portfolio companies.

Altitude Life Science Ventures is a venture capital firm investing in early-stage life science companies. They focus on markets with strong demand and growth potential, and then back the highest-quality entrepreneurs.

Arboretum Ventures is a healthcare venture capital firm based in Ann Arbor, Michigan. They focus on early-stage investments in medical devices, life science tools, tech-enabled care delivery, and pharma adjacencies. Their investment strategy emphasizes under-ventured opportunities and building strong partnerships with entrepreneurs.

Brightstone Venture Capital manages a $100 million venture fund focused on early-growth stage investments. They leverage the partners' deep operating experience and successful investment background, primarily investing in technology and life sciences sectors.

CincyTech is a venture capital firm that invests in innovative founders tackling the world's complex challenges. Their experienced team partners early to help transform ideas into world-class companies.

Civilization Ventures is a venture capital firm investing in scientific founders focused on cutting-edge innovations in health tech and biology. They support founders with a "mentor capital" approach, leveraging their vast network of experienced biopharma executives. Their investments span genomics, diagnostics, digital health, and synthetic biology.

Decheng Capital is a global life sciences investment firm providing capital and strategic support to early-stage and growth-stage healthcare companies. They focus on companies with revolutionary technologies and strong market presence. Founded in 2012, Decheng has over $2 billion in capital.

Elm Street Ventures is a Yale-focused seed and early-stage venture fund based in New Haven, Connecticut. They invest in companies with a Yale connection, focusing on great people and great science to achieve great impact. Their investments typically range from $500,000 to $1 million initially, with potential for follow-on investments.

EQT Life Sciences, formerly LSP, is one of Europe’s largest and most experienced life sciences investors. They provide capital and strategic support to innovative companies developing therapeutics, medical devices, diagnostics, and healthtech globally. Their focus is on transforming scientific innovation into impactful healthcare solutions.

Forbion invests in life sciences companies in drug development and MedTech. They focus on addressing high medical needs and building breakthrough therapies.

Fountain Healthcare Partners is a venture fund providing risk capital and expertise to life sciences companies. They focus on a limited number of portfolio companies to provide extensive support beyond capital, acting as true partners in growth and risk mitigation. Their investments span from seed stage to public offerings, with a majority in Europe and the remainder in the US.